One possible explanation is the clonal heterogeneity of the primary tumour: ERα-negative cells could be more likely to disseminate, corresponding to the worse prognosis of predominantly ERα negative tumours and – inversely – to the demonstrated decreased invasiveness and metastatic potential of ERα-expressing breast cancer cells [20,21]. This evidence concerns the gene ESR1 and neoplasm.